0001127602-14-020443.txt : 20140624 0001127602-14-020443.hdr.sgml : 20140624 20140610162508 ACCESSION NUMBER: 0001127602-14-020443 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140609 FILED AS OF DATE: 20140610 DATE AS OF CHANGE: 20140610 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LABORATORY CORP OF AMERICA HOLDINGS CENTRAL INDEX KEY: 0000920148 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 133757370 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 BUSINESS PHONE: 3362291127 MAIL ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 FORMER COMPANY: FORMER CONFORMED NAME: NATIONAL HEALTH LABORATORIES HOLDINGS INC DATE OF NAME CHANGE: 19940314 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Boyle James T. Jr. CENTRAL INDEX KEY: 0001454748 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11353 FILM NUMBER: 14902364 MAIL ADDRESS: STREET 1: 531 SOUTH SPRING STREET CITY: BURLINGTON STATE: NC ZIP: 27215 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2014-06-09 0000920148 LABORATORY CORP OF AMERICA HOLDINGS LH 0001454748 Boyle James T. Jr. 531 SOUTH SPRING STREET BURLINGTON NC 27215 1 EVP, Chief Operating Officer Common Stock 2014-06-09 4 M 0 9800 84.86 A 35621 D Common Stock 2014-06-09 4 M 0 28800 84.86 A 64421 D Common Stock 2014-06-09 4 S 0 38600 103.00 D 25821 D Non-qualified Stock Options 84.86 2014-06-09 4 M 0 9800 0 D 2013-05-24 2022-05-23 Common Stock 9800 48100 D Non-qualified Stock Options 84.86 2014-06-09 4 M 0 28800 0 D 2013-05-24 2022-05-23 Common Stock 28800 19300 D The price of $103.00 per share represents a weighted average of sales prices ranging from $102.81 to $103.21 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2012 Omnibus Incentive Plan. The option vests in three equal annual installments beginning on the date reflected in this column. /s/ F. Samuel Eberts III, attorney-in-fact for James T. Boyle 2014-06-10